BLB&B Advisors LLC lifted its holdings in Zoetis Inc (NYSE:ZTS) by 5.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 50,460 shares of the company’s stock after acquiring an additional 2,478 shares during the quarter. BLB&B Advisors LLC’s holdings in Zoetis were worth $3,635,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also made changes to their positions in the company. Atria Investments LLC lifted its holdings in Zoetis by 25.3% during the 4th quarter. Atria Investments LLC now owns 15,330 shares of the company’s stock worth $1,104,000 after buying an additional 3,091 shares in the last quarter. Nisa Investment Advisors LLC raised its position in shares of Zoetis by 0.9% during the 4th quarter. Nisa Investment Advisors LLC now owns 253,456 shares of the company’s stock valued at $18,259,000 after acquiring an additional 2,180 shares during the last quarter. Daiwa SB Investments Ltd. increased its position in shares of Zoetis by 92.0% in the 4th quarter. Daiwa SB Investments Ltd. now owns 18,152 shares of the company’s stock valued at $1,308,000 after buying an additional 8,696 shares in the last quarter. Milestone Resources Group Ltd bought a new stake in shares of Zoetis in the 4th quarter valued at $40,294,000. Finally, Chesley Taft & Associates LLC bought a new stake in shares of Zoetis in the 4th quarter valued at $1,027,000. 93.14% of the stock is currently owned by institutional investors and hedge funds.
A number of equities analysts have issued reports on the company. BidaskClub cut Zoetis from a “strong-buy” rating to a “buy” rating in a report on Wednesday, September 20th. BMO Capital Markets raised their target price on shares of Zoetis from $65.00 to $70.00 and gave the company a “market perform” rating in a research note on Friday, November 3rd. Zacks Investment Research cut shares of Zoetis from a “buy” rating to a “hold” rating in a report on Wednesday, November 1st. Stifel Nicolaus reissued a “buy” rating and issued a $65.00 price target on shares of Zoetis in a report on Tuesday, October 24th. Finally, Cantor Fitzgerald reaffirmed a “buy” rating and set a $75.00 target price on shares of Zoetis in a report on Tuesday, September 26th. Two research analysts have rated the stock with a sell rating, four have assigned a hold rating and fourteen have issued a buy rating to the company. The company has a consensus rating of “Buy” and a consensus target price of $71.94.
Shares of Zoetis Inc (ZTS) traded up $0.26 during trading hours on Tuesday, reaching $75.65. 1,094,243 shares of the company were exchanged, compared to its average volume of 1,960,000. The company has a market capitalization of $36,830.00, a PE ratio of 39.82, a price-to-earnings-growth ratio of 1.90 and a beta of 1.06. The company has a debt-to-equity ratio of 2.45, a current ratio of 2.80 and a quick ratio of 1.95. Zoetis Inc has a fifty-two week low of $52.00 and a fifty-two week high of $76.40.
Zoetis (NYSE:ZTS) last announced its quarterly earnings data on Thursday, November 2nd. The company reported $0.65 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.63 by $0.02. The business had revenue of $1.35 billion for the quarter, compared to analysts’ expectations of $1.32 billion. Zoetis had a net margin of 18.29% and a return on equity of 62.39%. The firm’s quarterly revenue was up 8.5% compared to the same quarter last year. During the same period last year, the firm posted $0.52 earnings per share. sell-side analysts predict that Zoetis Inc will post 2.37 EPS for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, March 1st. Investors of record on Friday, January 19th will be paid a $0.126 dividend. This represents a $0.50 dividend on an annualized basis and a yield of 0.67%. This is a boost from Zoetis’s previous quarterly dividend of $0.11. The ex-dividend date of this dividend is Thursday, January 18th. Zoetis’s dividend payout ratio (DPR) is 22.11%.
ILLEGAL ACTIVITY NOTICE: “Zoetis Inc (ZTS) Stake Lifted by BLB&B Advisors LLC” was first posted by Transcript Daily and is owned by of Transcript Daily. If you are reading this piece of content on another publication, it was illegally stolen and reposted in violation of US and international copyright and trademark legislation. The original version of this piece of content can be viewed at https://transcriptdaily.com/2018/01/16/zoetis-inc-zts-stake-lifted-by-blbb-advisors-llc.html.
Zoetis Inc is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals), and within five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.
Want to see what other hedge funds are holding ZTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc (NYSE:ZTS).
Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.